What Happened?
Wexford, PA-based Coeptis-Therapeutics Appointed Brian Cogley as Chief Financial Officer
Date of management change: May 17, 2023
Wexford, PA-based Coeptis-Therapeutics Appointed Brian Cogley as Chief Financial Officer
Coeptis Therapeutics Holdings, Inc., together with its subsidiaries including Coeptis Therapeutics, Inc. and Coeptis Pharmaceuticals, Inc., (collectively "Coeptis"), is a biopharmaceutical company developing innovative cell therapy platforms for cancer that have the potential to disrupt conventional treatment paradigms and improve patient outcomes. Coeptis` product portfolio and rights are highlighted by a universal, multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), and intellectual property and knowhow related to the GEAR™ cell therapy and companion diagnostic platforms, which Coeptis is developing with VyGen-Bio and leading medical researchers at the Karolinska Institutet. Coeptis` business model is designed around maximizing the value of its current product portfolio and rights through in-license agreements, out-license agreements and co-development relationships, as well as entering into strategic partnerships to expand its product rights and offerings, specifically those targeting cancer. The Company is headquartered in Wexford, PA.
Brian Cogley is Chief Financial Officer at Coeptis Therapeutics. Previously, Brian held various senior HR leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Walker Kent, Lefebvre Jamie, Morrissey Patrick, Dunn Jeanette, Snider Rich, Bowman Elaine, Danilovich Yann, Kamppari Merja, Lockhart Travis, Delbue Roger, Wragg Catherine
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.